Public health reviews · 2026
Machine Learning Used in Communicable Disease Control: A Scoping Review.
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Birdi Sharon, Patel Atushi, Rabet Roxana, Singh Navreet, Durant Steve, Vosoughi Tina, Kapra Faris, Shergill Mahek, Mesfin Elnathan, Ziegler Carolyn, Ali Shehzad, Buckeridge David, Ghassemi Marzyeh, Gibson Jennifer, John-Baptiste Ava, Macklin Jillian, Mccradden Melissa, Mckenzie Kwame, Mishra Sharmistha, Naraei Parisa, Owusu-Bempah Akwasi, Rosella Laura, Shaw James, Upshur Ross, Pinto Andrew D
Аннотация
OBJECTIVES: Communicable diseases continue to threaten global health, with COVID-19 as a recent example. Rapid data analysis using machine learning (ML) is crucial for detecting and controlling outbreaks. We aimed to identify how ML approaches have been applied to achieve public health objectives in communicable disease control and to explore algorithmic biases in model design, training, and implementation, and strategies to mitigate these biases.
METHODS: We searched MEDLINE, Embase, Cochrane Central, Scopus, ACM DL, INSPEC, and Web of Science to identify peer-reviewed studies from 1 January 2000, to 15 July 2022. Included studies applied ML models in population and public health to address ten communicable diseases with high prevalence.
RESULTS: 28,378 citations were retrieved, and 209 met our inclusion criteria. ML for communicable diseases has risen since 2020, particularly for SARS-CoV-2 (n = 177), followed by malaria, HIV, and tuberculosis. Eighteen studies (8.61%) considered bias, and only eleven implemented mitigation strategies.
CONCLUSION: A growing number of studies used ML for disease surveillance. Addressing biases in model design should be prioritized in future research to improve reliability and equity in public health outcomes.
METHODS: We searched MEDLINE, Embase, Cochrane Central, Scopus, ACM DL, INSPEC, and Web of Science to identify peer-reviewed studies from 1 January 2000, to 15 July 2022. Included studies applied ML models in population and public health to address ten communicable diseases with high prevalence.
RESULTS: 28,378 citations were retrieved, and 209 met our inclusion criteria. ML for communicable diseases has risen since 2020, particularly for SARS-CoV-2 (n = 177), followed by malaria, HIV, and tuberculosis. Eighteen studies (8.61%) considered bias, and only eleven implemented mitigation strategies.
CONCLUSION: A growing number of studies used ML for disease surveillance. Addressing biases in model design should be prioritized in future research to improve reliability and equity in public health outcomes.